Publications by authors named "Jean Geneve"

Claim this Profile
A
A phase III trial of docetaxel-estramustine in high-risk localised prostate cancer: a planned analysis of response, toxicity and quality of life in the GETUG 12 trial.
Karim Fizazi, Francois Lesaunier, Remy Delva, Gwenaëlle Gravis, Frederic Rolland, Jean Geneve

Eur J Cancer· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase II multicentre trial.
Etienne G C Brain, Cécile Mertens, Véronique Girre, Frédérique Rousseau, Emmanuel Blot

Crit Rev Oncol Hematol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
François Bertucci, Nathalie Borie, Henri Roche, Thomas Bachelot, Jean-Marc Le Doussal, Jean Geneve

Breast Cancer Res Treat· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial.
Marc Ychou, Valérie Boige, Jean-Pierre Pignon, Thierry Conroy, Olivier Bouché

J Clin Oncol· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 38-gene expression signature to predict metastasis risk in node-positive breast cancer after systemic adjuvant chemotherapy: a genomic substudy of PACS01 clinical trial.
Pascal Jézéquel, Mario Campone, Henri Roché, Wilfried Gouraud, Catherine Charbonnel

Breast Cancer Res Treat· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen.
Mario Campone, Loïc Campion, Henry Roché, Wilfried Gouraud, Catherine Charbonnel

Breast Cancer Res Treat· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy, heat, flavours and aromas of Microbial Biotechnology.
Matilde Fernández, Paloma Pizarro-Tobías, Jean de Genève

Microb Biotechnol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New avenues for Microbial Biotechnology: the beginning of a golden era.
Jean De Genève, Matilde Fernández

Microb Biotechnol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decision-making and breast cancer clinical trials: how experience challenges attitudes.
Julien Mancini, Jean Genève, Florence Dalenc, Dominique Genre, Alain Monnier

Contemp Clin Trials· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III double-blind, placebo-controlled study of thalidomide in extensive-disease small-cell lung cancer after response to chemotherapy: an intergroup study FNCLCC cleo04 IFCT 00-01.
Jean Louis Pujol, Jean Luc Breton, Radj Gervais, Marie-Laure Tanguy, Elisabeth Quoix

J Clin Oncol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of care by breast cancer patients participating or not participating in a randomized controlled trial: a report with the Patients' Committee for Clinical Trials of the Ligue Nationale Contre le Cancer.
Claire Julian-Reynier, Jean Genève, Florence Dalenc, Dominique Genre, Alain Monnier

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential adjuvant epirubicin-based and docetaxel chemotherapy for node-positive breast cancer patients: the FNCLCC PACS 01 Trial.
Henri Roché, Pierre Fumoleau, Marc Spielmann, Jean-Luc Canon, Thierry Delozier

J Clin Oncol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Production of a common catalogue for several "Centres Régionaux de Lutte Contre le Cancer": a "Fédération des Centres de Lutte Contre le Cancer" project].
Emmanuel Reyrat, Jean Genève

Med Sci (Paris)· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Demand grows for early access to promising cancer drugs.
Jean Genève

J Natl Cancer Inst· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis